Bioequivalence and Bioavailability Forum

Dear Both,

Thanks for the reply.

My other concern was safety (after ruling out p/k interaction). I want to know how one will be able to differentiate that a particular adverse event is because of study mediction or due to prophylactic drug.

Finally, Is such study data acceptable by regulatory authorities because i came across no examples of such studies during my search on internet.

Thanks & Regards,

Deepak

--
Edit: Full quote removed. Please see this post! [Jaime]